-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$58.574.85% Upside
Recent Analyst Forecasts and Stock Ratings
Revolution Medicines, Inc. Frequently Asked Questions
-
What analysts cover Revolution Medicines, Inc.?
Revolution Medicines, Inc. has been rated by research analysts at Guggenheim, Oppenheimer, Piper Sandler, Needham, Wedbush, Stifel Nicolaus in the past 90 days.